Prion protein monoclonal antibody (PRN100) therapy for Creutzfeldt–Jakob disease: evaluation of a first-in-human treatment programme

2022/03/16 by Simon Mead, Azadeh Khalili-Shirazi, Caroline Potter +18 · 1 citation
Biochemistry, Genetics and Molecular Biology · Medicine · #Healthcare and Venom Research #Peripheral Neuropathies and Disorders #Prion Diseases and Protein Misfolding

paper · pdf · doi:10.1016/s1474-4422(22)00082-5

openalex publication_date 2022/03/16 · crossref created 2022/03/16 · crossref issued 2022/04/01 · crossref published 2022/04/01 · crossref published-print 2022/04/01 · openalex created_date 2022/04/03 · crossref deposited 2025/10/26 · crossref indexed 2026/07/14 · openalex updated_date 2026/07/29

Citations

• Safety and efficacy of quinacrine in human prion disease (PRION-1 study): a patient-preference trial
• Kuru in the 21st century—an acquired human prion disease with very long incubation periods

Cited by

• Creutzfeldt–Jakob disease [wikipedia]